RNAi Oxford
@RNAiOxfordJoin our Oxford RNAi conferences - RNAi2021 (11th international) will be held virtually from Oxford on 31st March 2021. We hope to see you there.
Similar User
@RTI_UMassChan
@ChemEurJ
@ViridianThera
@MacroJrnls_ACS
@JPhysChem
@nchembio
@cellhostmicrobe
@embojournal
@ChemMater
@ACS_Sensors
@Magda_Skipper
@NatProdReports
@OTSociety
@Non_Coding_RNA
@Co_Biologists
#RNAi 2021 (Oxford) Virtual website is live: lpmhealthcare.com/rnai-2021-virt… Oral & poster abstracts on RNAi/small RNA research & application, in particular from final year doctoral students, early/mid career postdocs & /junior group leaders are welcome. #RNAiOx21V #siRNA #miRNA #RNA
Analysis of polyethylenimine (PEI)-based polyplexes and lipopolyplexes for pulmonary #siRNA delivery in 2D- and air-liquid interface culture by Sandra Noske and colleagues lpmhealthcare.com/rnai-2021-virt… #RNAiOx21V, #SNoske #RNAi
Tyrosine-modified PEI for highly efficacious and biocompatible #siRNA delivery in vitro, ex vivo and in vivo by Michael Karimov and colleagues #RNAiOx21V, #MKarimov #RNAi
Non-targeting control for MISSION #shRNA library leads to SNRPD3 transcript downregulation and inhibition of cell proliferation by Maria Czarnek and colleagues #RNAiOx21V, #MCzarnek lpmhealthcare.com/rnai-2021-virt…
The Oxford #RNAi conference will be on 31st March. Registration is still open. View agenda on the following link: lpmhealthcare.com/rnai-2021-virt… #RNAInterference #GeneSilencing
Final programme of #RNAi 2021 (Oxford) Virtual (31 March 2021) is now available on the following link: lpmhealthcare.com/rnai-2021-virt… #RNAiOx21V #GeneSilencing #RNAInterference #Genomics There is still time to register. Any questions, drop us an email.
Best wishes for the festive season and a very happy and safe New Year to all our friends and colleagues, and their loved ones.
Assessment of #Aptamer-Targeted Contrast Agents for Monitoring of Blood Clots in CT and Fluoroscopy Imaging @koudrina @MariaCDeRosa @SassStem @aptamer_connect @BurkeLabRNA @HTSohLab @mallikaratchy @Bluebird__47 @hocekm @bionaloo @AshPMenon pubmed.ncbi.nlm.nih.gov/33232126/
Now online! Commensal #microbiota regulate #interferon signaling to #protect against #pathogenic #viral #infections. bit.ly/35FMkmY
Congrats @moderna_tx! #Science and biomedical #innovation are the answer for #covid19! Adding to last week’s news from @pfizer, we can see the light at end of tunnel! finance.yahoo.com/news/moderna-c…
#COVID19 superspreading events have been reported globally, happening in bars and barbecues, factories and schools, and even at the White House. But why do these disease clusters occur—and why are they so important? Learn more in our data visualization: fcld.ly/nbfcfjw
In the latest issue! Structurally resolved #SARSCoV2 #antibody shows high efficacy in severely #infected hamsters and provides a potent #cocktail pairing strategy bit.ly/32DZMG0 For @CellPressNews #coronavirus research, visit cell.com/2019-nCOV #COVID19
Recent research in @SciRobotics presented a battery-free, sweat-powered #eskin that can be worn like a patch on human skin, where it senses metabolic biomarkers during prolonged physical activity and wirelessly transmits these data via #Bluetooth: fcld.ly/fovthar
Microbes’ mystery DNA helps defeat viruses—and has genome-editing potential sciencemag.org/news/2020/11/m…
The FDA’s attention on digital therapeutics during the pandemic suggests that the agency is recognizing them as legitimate, and even necessary, for human health
Scientists have detected preexisting antibody-driven immunity against #SARSCoV2 in a small proportion of individuals who were uninfected at the time of sampling. Read the research in Science: fcld.ly/d5z4pv2
🧬 - How has the gene-editing tool #CRISPR been applied in the fight against #COVID19? Find out in this month’s technology news feature from @StraitonJenny
We are pleased to share topline results from our ILLUMINATE-B Phase 3 study of lumasiran, an investigational #RNAi therapeutic for the treatment of primary #hyperoxaluria type 1 (PH1), in children under the age of 6. #raredisease #biotech
Schistosomiasis is a neglected tropical disease, caused by a parasitic flatworm, that kills 250,000 people every year. Scientists have discovered two new possible therapeutic targets using a large-scale RNA interference screen. @ScienceMagazine #RNAi ow.ly/qKXD50BECGx
#RNAi 2021 (Oxford) Virtual website is live: lpmhealthcare.com/rnai-2021-virt… Oral & poster abstracts on RNAi/small RNA research & application, in particular from final year doctoral students, early/mid career postdocs & /junior group leaders are welcome. #RNAiOx21V #siRNA #miRNA #RNA
We must keep on protecting each other. Wash hands. Cover face. Make space.
United States Trends
- 1. #GMMTV2025 2,44 Mn posts
- 2. #tuesdayvibe 2.902 posts
- 3. HOBI 156 B posts
- 4. Good Tuesday 30 B posts
- 5. Canada 434 B posts
- 6. #26Nov 2.806 posts
- 7. #TuesdayFun N/A
- 8. #TuesdayMotivation N/A
- 9. Tariffs 139 B posts
- 10. Irene 297 B posts
- 11. HOSEOK 58,3 B posts
- 12. Buy American 4.457 posts
- 13. Alec Baldwin 5.616 posts
- 14. Toyota 29 B posts
- 15. JHOPE 205 B posts
- 16. Pitchfork 3.625 posts
- 17. Tina Turner 3.391 posts
- 18. Fentanyl 49,1 B posts
- 19. Ginger 28,9 B posts
- 20. Bangladesh 283 B posts
Who to follow
-
RNA Therapeutics Institute
@RTI_UMassChan -
Chemistry
@ChemEurJ -
Viridian Therapeutics, Inc.
@ViridianThera -
ACS Macro Journals
@MacroJrnls_ACS -
The Journal of Physical Chemistry
@JPhysChem -
Nature Chemical Biology
@nchembio -
Cell Host & Microbe
@cellhostmicrobe -
The EMBO Journal
@embojournal -
Chemistry of Materials
@ChemMater -
ACS Sensors
@ACS_Sensors -
Magdalena Skipper
@Magda_Skipper -
Nat. Prod. Reports
@NatProdReports -
Oligonucleotide Therapeutics Society
@OTSociety -
Non-Coding RNA
@Non_Coding_RNA -
The Company of Biologists
@Co_Biologists
Something went wrong.
Something went wrong.